SCHEDULE: SilverArc Capital Management Reports Stake in TELA BIO

SilverArc Capital Management, LLC and Devesh Gandhi have reported beneficial ownership of 4.8% of TELA BIO, Inc.'s Class A Common Stock as of June 30, 2026.

Summary

• SilverArc Capital Management, LLC and Devesh Gandhi (collectively, the "Reporting Persons") have filed a Schedule 13G.
• This filing indicates that as of June 30, 2026, the Reporting Persons beneficially owned 2,137,201 shares of TELA BIO, Inc. Class A Common Stock.
• This ownership stake represents 4.8% of the class of securities.
• The Reporting Persons have shared power to vote and shared power to dispose of these shares.
• SilverArc Capital Management, LLC is a Delaware limited liability company, and Devesh Gandhi is a U.S. citizen.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new strategic or financial information.

Positives

• Reporting Persons hold a significant minority stake (4.8%) in TELA BIO, Inc., indicating investor interest.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a standard investment approach.

Negatives

• The filing does not provide any new financial performance data or strategic updates for TELA BIO, Inc.

Risks

• Potential for increased shareholder activism or influence from the Reporting Persons due to their significant stake.
• Market reaction to the disclosure of a new substantial shareholder could lead to short-term volatility.

Future Outlook

The filing itself does not contain forward-looking statements or guidance regarding TELA BIO, Inc.'s future performance. It solely reports on beneficial ownership.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders. This filing indicates a notable investment by SilverArc Capital Management in the biotechnology sector, specifically within TELA BIO, Inc.

Stakeholder Impact

• Shareholders: May view the increased stake as a sign of confidence or potential for future strategic involvement, possibly impacting share price.
• Management: May need to engage with the Reporting Persons regarding their investment and potential influence.
• Creditors: No direct impact indicated by this filing.

Next Steps

• Continued monitoring of TELA BIO, Inc.'s performance and any subsequent filings by SilverArc Capital Management or Devesh Gandhi.
• Potential for further disclosures if the Reporting Persons' ownership stake changes significantly.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, SilverArc Capital Management, Devesh Gandhi, TELA BIO, Class A Common Stock, Investment Holding